AdaptHealth Financials - Benzinga

AdaptHealth Corp

AHCONASDAQ

Trade with Public

Trade with Public

$5.67

0.020.35%

近くで: Sep 29, 5:00 PM EST

$5.67

N/A

時間外: 4:00 PM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

AdaptHealth Financials

AdaptHealth (AHCO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
UPDATE: AdaptHealth Q2 Adj. EPS $0.08 Misses $0.17 Estimate

AdaptHealth (NASDAQ:AHCO) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.17 by 52.94 percent. This is a 20 percent decrease over earnings of $0.10 per share from the

Benzinga Newsdesk

PRO
AdaptHealth Lowers FY2026 Sales Guidance from $3.450B-$3.520B to $2.850B-$2.890B vs $3.488B Est

AdaptHealth (NASDAQ:AHCO) lowers FY2026 sales outlook from $3.450 billion-$3.520 billion to $2.850 billion-$2.890 billion vs $3.488 billion estimate.

Benzinga Newsdesk

PRO
AdaptHealth Q2 EPS $(0.99) Misses $0.18 Estimate, Sales $740.300M Miss $848.627M Estimate

AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.99) per share which missed the analyst consensus estimate of $0.18 by 650 percent. This is a 1090 percent decrease over earnings of $0.10 per share from the

Benzinga Newsdesk

PRO
CORRECTION: AdaptHealth Q1 Adj. EPS $(0.05) Misses $0.02 Estimate, Sales $819.799M Beat $796.621M Estimate

AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.02 by 350 percent. This is unchanged from the same period last year. The company reported

Benzinga Newsdesk

PRO
AdaptHealth Raises FY2026 Sales Guidance from $3.440B-$3.510B to $3.450B-$3.520B vs $3.463B Est

AdaptHealth (NASDAQ:AHCO) raises FY2026 sales outlook from $3.440 billion-$3.510 billion to $3.450 billion-$3.520 billion vs $3.463 billion estimate.

Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

© 2026 Benzinga | All Rights Reserved